Cargando…
A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients
Huntington’s disease (HD) is a progressive neurodegenerative disease. Involuntary movements, cognitive impairment and psychiatric disturbance are the major clinical manifestations, and gradual atrophy and selective neuronal loss in the striatum and cerebral cortex are the pathologic hallmarks. HD is...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664763/ https://www.ncbi.nlm.nih.gov/pubmed/31358058 http://dx.doi.org/10.1186/s40478-019-0764-9 |
_version_ | 1783439953172103168 |
---|---|
author | Liu, Peng Smith, Benjamin R. Huang, Eric S. Mahesh, Abhishek Vonsattel, Jean Paul G. Petersen, Ashley J. Gomez-Pastor, Rocio Ashe, Karen H. |
author_facet | Liu, Peng Smith, Benjamin R. Huang, Eric S. Mahesh, Abhishek Vonsattel, Jean Paul G. Petersen, Ashley J. Gomez-Pastor, Rocio Ashe, Karen H. |
author_sort | Liu, Peng |
collection | PubMed |
description | Huntington’s disease (HD) is a progressive neurodegenerative disease. Involuntary movements, cognitive impairment and psychiatric disturbance are the major clinical manifestations, and gradual atrophy and selective neuronal loss in the striatum and cerebral cortex are the pathologic hallmarks. HD is caused by expanded CAG trinucleotide repeats at the N-terminus of IT15 that encodes the huntingtin (HTT) protein, though the molecular mechanisms through which the mutant HTT (mHTT) exerts toxic effects remain obscure. Members of the caspase family, including caspase-2 (Casp2), play an important role in HD pathogenesis. Genetic ablation of Casp2 ameliorates cognitive and motor deficits of HD mice, though the molecular targets of Casp2 are still unclear. It is well established that the microtubule-associated protein tau potentiates cognitive dysfunction in a variety of neurodegenerative disorders, including HD. Our recent study indicates that Casp2-catalyzed tau cleavage at aspartate 314 (tau 2N4R isoform numbering system) mediates synaptotoxicity, cognitive deficits and neurodegeneration in cellular and mouse models of frontotemporal dementia; further, levels of Δtau314, the soluble, N-terminal cleavage product, are elevated in individuals with mild cognitive impairment and Alzheimer’s disease, compared with cognitively normal individuals. Here, we identified the presence of Δtau314 proteins in the striatum (caudate nucleus) and prefrontal cortex (Brodmann’s area 8/9) of human subjects, and showed that in both structures, levels of Casp2 and Δtau314 proteins correlate well, and both proteins are higher in HD patients than non-HD individuals. Our findings advance our understanding of the contribution of Casp2-mediated Δtau314 production to HD pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0764-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6664763 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66647632019-08-05 A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients Liu, Peng Smith, Benjamin R. Huang, Eric S. Mahesh, Abhishek Vonsattel, Jean Paul G. Petersen, Ashley J. Gomez-Pastor, Rocio Ashe, Karen H. Acta Neuropathol Commun Research Huntington’s disease (HD) is a progressive neurodegenerative disease. Involuntary movements, cognitive impairment and psychiatric disturbance are the major clinical manifestations, and gradual atrophy and selective neuronal loss in the striatum and cerebral cortex are the pathologic hallmarks. HD is caused by expanded CAG trinucleotide repeats at the N-terminus of IT15 that encodes the huntingtin (HTT) protein, though the molecular mechanisms through which the mutant HTT (mHTT) exerts toxic effects remain obscure. Members of the caspase family, including caspase-2 (Casp2), play an important role in HD pathogenesis. Genetic ablation of Casp2 ameliorates cognitive and motor deficits of HD mice, though the molecular targets of Casp2 are still unclear. It is well established that the microtubule-associated protein tau potentiates cognitive dysfunction in a variety of neurodegenerative disorders, including HD. Our recent study indicates that Casp2-catalyzed tau cleavage at aspartate 314 (tau 2N4R isoform numbering system) mediates synaptotoxicity, cognitive deficits and neurodegeneration in cellular and mouse models of frontotemporal dementia; further, levels of Δtau314, the soluble, N-terminal cleavage product, are elevated in individuals with mild cognitive impairment and Alzheimer’s disease, compared with cognitively normal individuals. Here, we identified the presence of Δtau314 proteins in the striatum (caudate nucleus) and prefrontal cortex (Brodmann’s area 8/9) of human subjects, and showed that in both structures, levels of Casp2 and Δtau314 proteins correlate well, and both proteins are higher in HD patients than non-HD individuals. Our findings advance our understanding of the contribution of Casp2-mediated Δtau314 production to HD pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0764-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-30 /pmc/articles/PMC6664763/ /pubmed/31358058 http://dx.doi.org/10.1186/s40478-019-0764-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Liu, Peng Smith, Benjamin R. Huang, Eric S. Mahesh, Abhishek Vonsattel, Jean Paul G. Petersen, Ashley J. Gomez-Pastor, Rocio Ashe, Karen H. A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients |
title | A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients |
title_full | A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients |
title_fullStr | A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients |
title_full_unstemmed | A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients |
title_short | A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients |
title_sort | soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of huntington’s disease patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664763/ https://www.ncbi.nlm.nih.gov/pubmed/31358058 http://dx.doi.org/10.1186/s40478-019-0764-9 |
work_keys_str_mv | AT liupeng asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT smithbenjaminr asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT huangerics asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT maheshabhishek asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT vonsatteljeanpaulg asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT petersenashleyj asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT gomezpastorrocio asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT ashekarenh asolubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT liupeng solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT smithbenjaminr solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT huangerics solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT maheshabhishek solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT vonsatteljeanpaulg solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT petersenashleyj solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT gomezpastorrocio solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients AT ashekarenh solubletruncatedtauspeciesrelatedtocognitivedysfunctionandcaspase2iselevatedinthebrainofhuntingtonsdiseasepatients |